We’re excited to be sharing an update on the progress of #GBMAGILE at #ASCO2021 To see the full abstract, visit: https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.TPS2074GBM AGILE - latest anticipated Global Expansion of sites to accept trial patients.US - 6 additional sites to be activated in 2021.
Canada - 3 additional sites to be activated in 2021.
Europe -27 site activation in 5 countries Q2 to Q3 in 2021.
China - Site activation Q4 2021 to Q1 2022.
Excellent worldwide patient recruitment happening.
Regards.